PRA Health Sciences melantik pegawai kanan FDA untuk mengetuai Pusat Kecemerlangan Global untuk Strategi Kajian Klinikal Terpencar
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hari ini mengumumkan pelantikan Isaac Rodriguez-Chavez, PhD, MHS, MS sebagai Timbalan Presiden Kanan, Hal...
PRAヘルスサイエンス、FDAシニアオフィサーを分散型臨床試験戦略のグローバル･センター･オブ･エクセレンス統括者に任命
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
ノースカロライナ州ローリー発, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、アイザック･ロドリゲス･チャベス (Isaac Rodriguez-Chavez) 博士 (保健学修士、理学修士)...
PRA Health Sciences 任命高級 FDA 官員領導新全球分散式臨床試驗策略卓越中心
23 nov. 2020 14h28 HE
|
PRA Health Sciences, Inc.
北卡羅萊納州拉里格, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈任命 Isaac Rodriguez-Chavez 博士、環境健康科學碩士兼理學碩士為科學和臨床事務高級副總裁。他將領導公司的全球分散式臨床試驗策略卓越中心。Rodriguez-Chavez 博士的職責包括實現...
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
19 nov. 2020 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance
04 nov. 2020 16h01 HE
|
PRA Health Sciences, Inc.
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
PRA Health Sciences to Report Third Quarter 2020 Earnings
07 oct. 2020 17h09 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
PRA Health Sciences seleccionada por BARDA para formar parte de su Red de Estudios Clínicos exclusiva
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy que fue seleccionada por la Autoridad de Investigación y Desarrollo Avanzado...
PRA Health Sciences selecionada pela BARDA como membro da sua exclusiva Rede de Estudos Clínicos
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences , Inc.(NASDAQ: PRAH) anunciou hoje que foi selecionada pela Biomedical Advanced Research and Development Authority (BARDA) como...
PRAヘルスサイエンス、BARDAにより専門臨床研究ネットワークのメンバーに選出
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
PRAは新たな契約の下、公衆衛生の医学的対策開発で生物医学先端研究開発局 (BARDA) を支援 ノースカロライナ州ローリー, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、生物医学先端研究開発局 (Biomedical Advanced Research...
BARDA 選擇 PRA Health Sciences 作為為其專屬臨床研究網絡的成員
07 oct. 2020 11h10 HE
|
PRA Health Sciences, Inc.
新澤西州拉里市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈公司已獲生物醫學高級研究和開發管理局 (BARDA) 選為最新臨床研究網絡 (CSN) 的成員。PRA 獲授予臨床試驗計劃和執行 (CTPE)...